Alaunos Therapeutics, Inc. (TCRT) Tops Q4 EPS by 1c

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance